The novel index using preoperative C-reactive protein and neutrophil-to-lymphocyte ratio predicts poor prognosis in patients with pancreatic cancer.

Tomohiko TaniaiKoichiro HarukiKenei FurukawaShinji OndaJungo YasudaYoshihiro ShiraiTakeshi GochoMitsuru YanagakiRyoga HamuraHiroaki ShibaToru Ikegami

Published in: International journal of clinical oncology (2021)

Preoperative C-NLR can be a prognostic indicator in patients with PC after pancreatic resection, suggesting the importance of both CRP and blood cell count in predicting therapeutic outcomes.

Keyphrases

poor prognosis
long non coding rna
patients undergoing
single cell
cell therapy
peripheral blood
stem cells
skeletal muscle
bone marrow
mesenchymal stem cells